🔎 Trials Near Me

Beranda › Obesitas › Texas › The Woodlands

Uji klinis Obesitas di The Woodlands, TX

12 studi untuk Obesitas mencari peserta di lokasi sekitar The Woodlands (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Tcr Institute Llc, Kingwood · 20 mi jauhnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 5 Okt 2026 · NCT07037433

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Menerima pesertaFase 2
  • Texas Cardiology Associates of Houston, Kingwood · 20 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07783802

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Menerima pesertaFase 3
  • Martin Diagnostic Clinic, Tomball · 9 mi jauhnya
Usia 6 hingga 17 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • Activian Clinical Research, Kingwood · 20 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Menerima pesertaFase 3
  • AURORA-2 Clinical Site, Tomball · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • Northwest Houston Clinical Research PLLC, Tomball · 9 mi jauhnya
  • Javara Research, Conroe · 11 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 3
  • AURORA-1 Clinical Site, Tomball · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Menerima pesertaFase 3
  • DM Clinical Research, Tomball · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Tomball · 9 mi jauhnya
  • Kailera Clinical Site, Kingwood · 20 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Menerima pesertaFase 3
  • Kailera Clinical Site, Tomball · 9 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Menerima pesertaFase 3
  • Northwest Houston Heart Center, Tomball · 9 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07575399

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Javara Inc. / Privia Medical Group Gulf Coast PLLC, Conroe · 11 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

Uji klinis Obesitas di kota lain

Studi lain di The Woodlands

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.